Suchergebnisse - "Nahi, Hareth"

PubPharm (207)

1

Effectiveness and infectious complications of BCMA T-cell engagers in treating multiple myeloma : Real-world evidence from Sweden

enthalten in: Cancer medicine | 2024

von Uttervall, K. | Tätting, L. | Lemonakis, K. | +6

2

In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease

enthalten in: Blood cancer journal | 2024

von Lund, T. | Gundesen, M. | Juul Vangsted, A. | +12

3

Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma : A Phase 2 Multicenter Study by the Nordic Myeloma Study Group

enthalten in: Cancers | 2024

von Partanen, A. | Waage, A. | Peceliunas, V. | +26

4

Effectiveness and infectious complications of BCMA T‐cell engagers in treating multiple myeloma : Real‐world evidence from Sweden

enthalten in: Cancer Medicine | 2024

von Uttervall, K. | Tätting, L. | Lemonakis, K. | +6

5

Minimal residual disease status is the prognostic determinant following high-dose treatment for patients with multiple myeloma

enthalten in: Cancer medicine | 2023

von Nahi, H. | Afram, G. | Uttervall, K. | +8

6

Potential value of pre-planned imaging of bone disease in multiple myeloma

enthalten in: Blood cancer journal | 2023

von Gundesen, M. | Asmussen, J. | Schjesvold, F. | +12

7

Generation of NK cells with chimeric-switch receptors to overcome PD1-mediated inhibition in cancer immunotherapy

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Susek, K. | Schwietzer, Y. | Karvouni, M. | +10

8

Plain language summary of the MAIA study of daratumumab plus lenalidomide and dexamethasone for the treatment of people with newly diagnosed multiple myeloma

enthalten in: Future oncology | Apr 2023

von Facon, T. | Kumar, S. | Plesner, T. | +21

9

Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX) : A Randomized, Open-Label, Phase III Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Dimopoulos, M. | Oriol, A. | Nahi, H. | +19

10

Response to Caravita di Toritto and Rago

enthalten in: European journal of haematology | 2023

von Chaireti, R. | Uttervall, K. | Luong, V. | +6

CommentOn: Eur J Haematol. 2023 Feb;110(2):221. - PMID 36300853

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[21]